Tanith Carey, author of new book What’s my Baby Thinking?, offers a roadmap for new parents struggling to maintain their ...

Vertex stock dipped late Monday despite better-than-expected third-quarter metrics and a slight sales guidance boost.

Plant a seed and, if the conditions are right, the seed grows. The process seems simple enough at first glance and is something many of us may feel like we learned in elementary school.

Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced the launch of AdvanceAD-Tx™, a gene expression profile (GEP) test ...

This was a new position; the IBB stake now accounts for 8.7% of Florin Court Capital LLP’s 13F AUM Top five holdings after ...

COPENHAGEN (Reuters) -Denmark's Novo Nordisk said on Monday it is confident that its proposed takeover of U.S. drugmaker ...

The ASX biotech sector ran strongly in October, but the big-cap thoroughbreds found the track conditions more challenging.

Novartis will acquire Avidity Biosciences for $12 billion at $72 per share, gaining its RNA-targeting platform and neuroscience pipeline as Avidity spins off its precision cardiology programs into a ...

Pfizer is suing Novo Nordisk following the Danish pharma's last-minute bid to acquire Metsera, which Pfizer called “reckless” ...

Dr. Vinay Prasad, who oversees FDA’s vaccine and biologics center, resigned in July after coming under fire from conservative ...

The average daily insulin dose for all 12 patients was also reduced by 92% ... Rachel Warren is a contributing Motley Fool stock market analyst covering pharmaceuticals, biotechnology, medical devices ...

A neurotechnology start-up claims to have achieved something that sounds like science fiction, transmitting a word from one ...